Results 41 to 50 of about 6,494 (198)
An Introduction to Boron Neutron Therapy (BNCT): Current Status and Future Outlook
Boron neutron capture therapy (BNCT) is based on the nuclear reaction, such that B-10 irradiated with low-energy thermal neutrons produces alpha particles with high linear energy transfer and lithium-7. Clinically, BNCT is used primarily for treatment of
Malehe Omrani +3 more
doaj
Although boron neutron capture therapy (BNCT) is a promising treatment option for malignant brain tumors, the optimal BNCT parameters for patients with immediately life-threatening, end-stage brain tumors remain unclear.
Yi-Wei Chen +34 more
doaj +1 more source
Advances in Aptamer Drug Delivery Systems for Treatment of Glioblastoma
Aptamers have remarkable recognition capacity which is suitable for assisting drug delivery for GB. This review demonstrates that aptamers have great potential as targeted therapeutic carriers, conjugated to various therapeutic carriers, using a range of conjugation strategies and chemistries.
Alexandra R. Paul +4 more
wiley +1 more source
An orally administered, drug‐free hyaluronic acid nanoassembly, uhNAs‐OA, accumulates in the inflamed colon and is preferentially internalized by M1‐like macrophages via HA‐CD44 interactions. uhNAs‐OA scavenges excess ROS, suppresses NF‐κB signaling and remodels the colonic immune landscape, resulting in robust therapeutic efficacy in acute, chronic ...
Jianqin Wan +7 more
wiley +1 more source
Boron neutron capture therapy (BNCT) is a non-invasive therapeutic technique for treating malignant tumors, however, methods to evaluate its therapeutic efficacy and adverse reactions are lacking.
Shoji Imamichi +14 more
doaj +1 more source
Possibilities of boron neutron capture therapy in the treatment of malignant brain tumors
Boron neutron capture therapy (BNCT) that is of the highest attractiveness due to its selective action directly on malignant tumor cells is a promising approach to treating cancers.
V. V. Kanygin +3 more
doaj +1 more source
Nanocarriers have been recognized as an effective strategy for developing novel boron-containing delivery agents for boron neutron capture therapy (BNCT) of refractory tumors.
Taofeng Zhang +13 more
doaj +1 more source
Radiation shielding behavior of B4C‐reinforced UHMWPE composites. ABSTRACT The present study investigates the radiation shielding performance of ultra‐high molecular weight polyethylene (UHMWPE) composites reinforced with varying boron carbide (B4C) contents against low‐energy X‐rays through combined experimental and computational approaches.
Elif Altındaş +4 more
wiley +1 more source
Boron neutron capture therapy (BNCT) shows potential for the treatment of glioblastoma, the most aggressive form of primary brain tumor. Recently, ferroptosis, a cell death triggered by phospholipid peroxidation, has been identified as an important ...
Lin-Sheng Yu +4 more
doaj +1 more source
Experimental proof-of-concept and first field tests of the dual gamma-neutron imager GN-Vision [PDF]
GN-Vision is a compact dual-modality imaging system designed to simultaneously localize the spatial origin of γ-ray and slow neutron sources, with promising applications in hadron therapy, particularly Boron Neutron Capture Therapy (BNCT).
Sanchis-Moltó A. +18 more
doaj +1 more source

